Cleavage and Secretion of Epstein-Barr Virus Glycoprotein 42 Promote Membrane Fusion with B Lymphocytes
Open Access
- 1 July 2009
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (13), 6664-6672
- https://doi.org/10.1128/jvi.00195-09
Abstract
Epstein-Barr virus (EBV) membrane glycoprotein 42 (gp42) is required for viral entry into B lymphocytes through binding to human leukocyte antigen (HLA) class II on the B-cell surface. EBV gp42 plays multiple roles during infection, including acting as a coreceptor for viral entry into B cells, binding to EBV glycoprotein H (gH) and gL during the process of membrane fusion, and blocking T-cell recognition of HLA class II-peptide complexes through steric hindrance. EBV gp42 occurs in two forms in infected cells, a full-length membrane-bound form and a soluble form generated by proteolytic cleavage that is secreted from infected cells due to loss of the N-terminal transmembrane domain. Both the full-length and the secreted gp42 forms bind to gH/gL and HLA class II, and the functional significance of gp42 cleavage is currently unclear. We found that in a virus-free cell-cell fusion assay, enhanced secretion of gp42 promoted fusion with B lymphocytes, and mutation of the site of gp42 cleavage inhibited membrane fusion activity. The site of gp42 cleavage was found to be physically distinct from the residues of gp42 necessary for binding to gH/gL. These results suggest that cleavage and secretion of gp42 are necessary for the process of membrane fusion with B lymphocytes, providing the first indicated functional difference between full-length and cleaved, secreted gp42.Keywords
This publication has 31 references indexed in Scilit:
- Structure of Epstein-Barr Virus Glycoprotein 42 Suggests a Mechanism for Triggering Receptor-Activated Virus EntryStructure, 2009
- Hydrophobic Residues That Form Putative Fusion Loops of Epstein-Barr Virus Glycoprotein B Are Critical for Fusion ActivityJournal of Virology, 2007
- Binding-Site Interactions between Epstein-Barr Virus Fusion Proteins gp42 and gH/gL Reveal a Peptide That Inhibits both Epithelial and B-Cell Membrane FusionJournal of Virology, 2007
- Epstein-Barr Virus EntryJournal of Virology, 2007
- Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial CellsJournal of Virology, 2006
- Soluble Epstein-Barr Virus Glycoproteins gH, gL, and gp42 Form a 1:1:1 Stable Complex That Acts Like Soluble gp42 in B-Cell Fusion but Not in Epithelial Cell FusionJournal of Virology, 2006
- Reactivation of Epstein-Barr virus from latencyReviews in Medical Virology, 2004
- Mutational Analyses of Epstein-Barr Virus Glycoprotein 42 Reveal Functional Domains Not Involved in Receptor Binding but Required for Membrane FusionJournal of Virology, 2004
- Mutational Analysis of the HLA Class II Interaction with Epstein-Barr Virus Glycoprotein 42Journal of Virology, 2003
- A Tumour Syndrome Affecting Children in Tropical AfricaPublished by Oxford University Press (OUP) ,1962